Clinical Trials Directory

Trials / Unknown

UnknownNCT02552706

The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis

The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis Among Very Low Birth Weight Infants With Formula-feeding

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
Shenzhen Bao'an Maternal and Child Health Hospital · Academic / Other
Sex
All
Age
3 Days
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy and its mechanisms of oral mixture probiotics in preventing necrotizing enterocolitis among the preterm very low birth weight infants.

Detailed description

Necrotizing enterocolitis (NEC) remains the most catastrophic gastrointestinal emergencies in preterm very low birth weight (VLBW) infants.Although study showed it is a multifactorial disease, its pathogenesis is still not yet unclear currently. Prematurity and formula feeding is considered as the main risk factors.Gut microbiota disturbance and immature immune system is associated with NEC. A lot of studies had showed that oral probiotics can alter gut microbiota flora colonization and reduce the incidence of NEC,but the exact mechanism remains unclear.The aim of this study is to elucidate the clinical efficacy and possible molecular mechanism of oral mixture probiotics in preventing NEC among preterm VLBW infants. Patient Registry procedures: First,randomized numbers was generated by the computer and sent to the principal investigator(PI) at each center when an infant was eligible for enrollment.Second, patient will be assigned randomly to experimental group or control group by PI.Finally,the PI at each center will be responsible for the accuracy,completeness or representativeness of medical records, registry forms,data collection. Sample size determination: The incidence of death and NEC was around 20% recently.To reduce the incidence of NEC and death to 10% at discharge would require a 50% improvement.At 80% power at P = 0.05 (two-sided),the loss rate of 0.2, this would require 135 subjects per arm. Statistical analysis:The two groups were compared by a Χ2-test for categorical variables,Mann-Whitney U Test were used when reporting medians.A P value of \<0.05 was considered statistically significant.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprobioticsAdministration of mixture probiotics 500mg by mouth, one time or divided into 2-4 times depends on the feeding volume until to 36 weeks post menstrual age.
DIETARY_SUPPLEMENTglucose solutionAdministration of 1 mL of a 5% glucose solution by mouth, one time or divided into 2-4 times depends on the feeding volume until to 36 weeks post menstrual age.

Timeline

Start date
2014-09-01
Primary completion
2017-01-01
Completion
2017-09-01
First posted
2015-09-17
Last updated
2016-03-29

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02552706. Inclusion in this directory is not an endorsement.